Statistics from Altmetric.com
A 69-year-old man with a recently diagnosed lung cancer with bone metastasis presented with a 2-week history of progressive weakness and confusion. The patient initially attributed the symptoms to the start of opioid therapy due to generalised pain. He was submitted to chemotherapy 4 days before admission and there were no relevant analytical changes, although there was no clinical improvement. Despite opioid rotation and pain control, there was a clinical worsening to a lethargic status. Besides severe psychomotor retardation, the patient was admitted with a subfebrile temperature, hypotension, tachycardia, decreased urinary output and global abdominal tenderness. Blood analysis revealed an important elevation of inflammatory markers (serum white blood count 13 000/μL; C reactive protein 32.4 mg/dL) as well as an acute kidney injury (blood urea nitrogen 105 mg/dL; plasmatic creatinine 2.6 mg/dL). An abdominal CT was performed and showed intramural gas dissecting the bladder wall with extension to the left kidney (figure 1), findings consistent with emphysematous cystitis and pyelonephritis. Broad-spectrum antibiotherapy with intravenous meropenem was started after blood and urine cultures were obtained. After 3 days, Klebsiella pneumonia e, sensitive to meropenem, grew in the urine culture, but haemocultures were negative. Despite the antibiotic treatment and consequent improvement of inflammatory markers, the patient developed severe neutropenia (absolute neutrophil count 40/μL), most likely related to chemotherapy, with no response to granulocyte-colony stimulating factor therapy. There was an adverse clinical evolution and the patient died from septic shock 10 days after admission.
Emphysematous cystitis is a rare urinary tract infection more commonly seen in immunocompromised patients, usually with non-specific symptoms that can be masked with medication.
Failure to recognise or diagnose this condition early in the course of the infection increases the associated mortality rate.
A complete clinical evaluation and high suspicion are needed to establish an early treatment and prevent the evolution of septic shock and death.
Contributors MMR: collected the clinical data and wrote the description of the attached 'Image in…'. CM and MML: revised the manuscript and approved it for publication. All the authors contributed to the management of the reported clinical case.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Next of kin consent obtained.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.